136 related articles for article (PubMed ID: 38759113)
41. Quantitative evaluation of the thickened dura mater impacting clinical signs in immune-mediated hypertrophic pachymeningitis.
Ikeda J; Shimojima Y; Yamada A; Sekijima Y
J Neurol Sci; 2023 Oct; 453():120780. PubMed ID: 37689000
[TBL] [Abstract][Full Text] [Related]
42. Immune-Mediated Hypertrophic Pachymeningitis and its Mimickers: Magnetic Resonance Imaging Findings.
Matias TB; Cordeiro RA; Duarte JA; de Jarry VM; Appenzeller S; Villarinho L; Reis F
Acad Radiol; 2023 Nov; 30(11):2696-2706. PubMed ID: 36882352
[TBL] [Abstract][Full Text] [Related]
43. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
Puéchal X; Iudici M; Pagnoux C; Cohen P; Hamidou M; Aouba A; Lifermann F; Ruivard M; Aumaître O; Bonnotte B; Maurier F; Le Gallou T; Hachulla E; Karras A; Khouatra C; Jourde-Chiche N; Viallard JF; Blanchard-Delaunay C; Godmer P; Le Quellec A; Quéméneur T; de Moreuil C; Mouthon L; Terrier B; Guillevin L;
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35296533
[TBL] [Abstract][Full Text] [Related]
44. Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.
Horino T; Takao T; Taniguchi Y; Terada Y
Clin Rheumatol; 2010 Jan; 29(1):111-3. PubMed ID: 19727912
[TBL] [Abstract][Full Text] [Related]
45. Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis.
Alba MA; Jennette JC; Hu Y; Poulton CJ; Blazek L; Derebail VK; Falk RJ; Hogan SL
Kidney Int Rep; 2022 Dec; 7(12):2676-2690. PubMed ID: 36506241
[TBL] [Abstract][Full Text] [Related]
46. Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis.
Monti S; Felicetti M; Delvino P; Padoan R; Berti A; Paolazzi G; Brunori G; Schiavon F; Caporali R; Montecucco C
Clin Exp Rheumatol; 2021; 39 Suppl 129(2):107-113. PubMed ID: 34014158
[TBL] [Abstract][Full Text] [Related]
47. Significance of clinical-immunological patterns and diagnostic yield of biopsies in microscopic polyangiitis and granulomatosis with polyangiitis.
Fernandes-Serodio J; Prieto-González S; Espígol-Frigolé G; Ríos-Garcés R; Gómez-Caverzaschi V; Araújo O; Espinosa G; Jordà-Sánchez R; Alba MA; Quintana L; Blasco M; Guillen E; Viñas O; Ruiz-Ortiz E; Pelegrín L; Sainz de la Maza M; Sánchez-Dalmau B; García-Herrera A; Solé M; Castillo P; Aldecoa I; Cano MD; Sellarés J; Hernández-González F; Agustí C; Lucena CM; López-Rueda A; Sánchez M; Benegas M; Capurro S; Sanmartí R; Grau JM; Vilaseca I; Alobid I; Cid MC; Hernández-Rodríguez J
J Intern Med; 2024 May; 295(5):651-667. PubMed ID: 38462959
[TBL] [Abstract][Full Text] [Related]
48. The visualization of hypertrophic pachymeningitis in antineutrophil cytoplasmic antibody-associated granulomatosis with polyangiitis on contrast-enhanced FLAIR.
Yoshikawa S; Ueda T
Radiol Case Rep; 2024 Jan; 19(1):418-423. PubMed ID: 38028296
[TBL] [Abstract][Full Text] [Related]
49. Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis.
Imafuku A; Sawa N; Kawada M; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Ubara Y; Takaichi K
Clin Rheumatol; 2019 Apr; 38(4):1039-1046. PubMed ID: 30483978
[TBL] [Abstract][Full Text] [Related]
50. [Case of cerebral venous thrombosis caused by MPO-ANCA associated hypertrophic pachymeningitis].
Saito T; Fujimori J; Yoshida S; Kaneko K; Kodera T
Rinsho Shinkeigaku; 2014; 54(10):827-30. PubMed ID: 25342019
[TBL] [Abstract][Full Text] [Related]
51. Hypertrophic spinal pachymeningitis caused by ANCA-associated vasculitis revealed by 18F-FDG PET/CT: A case report.
Wu M; Ren J; Luo Y
Medicine (Baltimore); 2021 Jan; 100(3):e24388. PubMed ID: 33546079
[TBL] [Abstract][Full Text] [Related]
52. Increased BAFF and APRIL levels in the cerebrospinal fluid of patients with anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.
Shimojima Y; Kishida D; Sekijima Y
Cytokine; 2017 Nov; 99():305-309. PubMed ID: 28847534
[TBL] [Abstract][Full Text] [Related]
53. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan.
Ono N; Niiro H; Ueda A; Sawabe T; Nishizaka H; Furugo I; Yoshizawa S; Yoshizawa S; Tsukamoto H; Kiyohara C; Tada Y; Horiuchi T
Rheumatol Int; 2015 Mar; 35(3):555-9. PubMed ID: 25129031
[TBL] [Abstract][Full Text] [Related]
54. [A case of MPO-ANCA positive hypertrophic pachymeningitis associated with vascular inflammation in the kidney biopsy].
Takewaki D; Tsuji Y; Kasai T; Yoshida T; Nakagawa M; Mizuno T
Rinsho Shinkeigaku; 2015; 55(11):844-7. PubMed ID: 26458570
[TBL] [Abstract][Full Text] [Related]
55. ANCA associated vasculitis in patients from Saudi Arabia.
Al Arfaj AS; Khalil N
Pak J Med Sci; 2018; 34(1):88-93. PubMed ID: 29643885
[TBL] [Abstract][Full Text] [Related]
56. [Atypical headache and facial pain as a result of hypertrophic pachymeningitis in C-ANCA-positive Wegener's granulomatosis].
Kuhn J; Weber M; Hedde JP; Bewermeyer H
Med Klin (Munich); 2005 Apr; 100(4):209-12. PubMed ID: 15834530
[TBL] [Abstract][Full Text] [Related]
57. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
[TBL] [Abstract][Full Text] [Related]
58. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
59. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Merkel PA; Polisson RP; Chang Y; Skates SJ; Niles JL
Ann Intern Med; 1997 Jun; 126(11):866-73. PubMed ID: 9163287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
